Specialty: Neurology and Psychiatry
Vincamine — time-proven efficacy and safety in treatment of patients with cerebrovascular diseasesOsadchy O.I. 1(1) (135) – I/II 2020 12
Spinal muscular atrophy: reality and future in UkraineShatillo A.V. Matyushenko V.M. 1(1) (135) – I/II 2020 16
Role of risk factors in the development of cognitive impairment in hypertensive patientsSkybchyk V.A. Pylypiv O.S. 1(2) (135) – I/II 2020 15
Differential diagnosis of epilepsy and movement disordersLitovchenko T.A. 1(1) (135) – I/II 2020 24
Comparative characteristics of epidemiology and clinics of multiple sclerosis in the south and north of Ukraine on the example of populations of the Nikolaev and Rivne regionsStoyanov A.M. Ivaniuk A.V. Grinchiuk A.D. Borisenko O.A.... 1(2) (135) – I/II 2020 14
Influence of oxidant stress on clinical manifestations and quality of life in patients with generalized myasthenia gravisKalbus O.I. 1(2) (135) – I/II 2020 18
Diagnosis and treatment of persistent viral infection and neuroinfectionsZozulya I.S. Kareta S.O. Volosovets A.O. Zozulya A.I.... 6(2) (134) – XI/XII 2019 15
Features of diagnostics and treatment of focal epilepsy in children (lecture)Stetsenko T.I. 6(1) (134) – XI/XII 2019 14
Features of nociceptive flexor reflex in patients with migraineRomanenko Y.I. 6(2) (134) – XI/XII 2019 7
Prognosing the severity of the myasthenia gravis
Method of transforaminal endoscopic microdiscectomy in the treatment of hernias of intervertebral discs of the lumbar spineGarmish A.R. Piontkovsky V.K. Fishchenko I.V. 4(2) (132) – VII/VIII 2019 5
Medical and statistical and epidemiological characteristics of the prevalence of myasthenia gravis in UkraineKalbus O.I. 4(2) (132) – VII/VIII 2019 8
Psychosomatic masks of anxiety
Evaluation of personal anxiety in patients with myasthenia gravisKalbus O.I. 3 (131) – V/VI 2019 17
Cognitive dysfunction and hypertension: literature review and own experiencePeleshko O.S. Skybchyk V.A. 3 (131) – V/VI 2019 168
